BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2956391)

  • 1. Elevated levels of plasma atrial natriuretic peptide in Bartter's syndrome fall to normal with indomethacin: implications for atrial natriuretic peptide regulation in man.
    Gordon RD; Tunny TJ; Klemm SA; Hamlet SM
    J Hypertens Suppl; 1986 Dec; 4(6):S555-8. PubMed ID: 2956391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin and atrial natriuretic peptide in Bartter's syndrome.
    Gordon RD; Tunny TJ; Klemm SA
    N Engl J Med; 1986 Aug; 315(7):459. PubMed ID: 2942775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Elevated atrial natriuretic peptide (ANP) levels and normotension in Bartter's syndrome in childhood].
    Di Pietro A; Proverbio MR; Capuano F; Chianese F; Coletta S; Catera P
    Pediatr Med Chir; 1993; 15(3):289-90. PubMed ID: 8415177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of atrial natriuretic peptide in man in primary aldosteronism, in Gordon's syndrome and in Bartter's syndrome.
    Tunny TJ; Higgins BA; Gordon RD
    Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):341-5. PubMed ID: 2942327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma and urinary prostaglandins in Bartter's and pseudo-Bartter's syndrome (author's transl)].
    Hornych A
    Nephrologie; 1980; 1(3):113-6. PubMed ID: 6945487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of posture and saline infusion on atrial natriuretic peptide and haemodynamics in patients with Bartter's syndrome and healthy controls.
    Doorenbos CJ; Daha MR; Bühler FR; Van Brummelen P
    Eur J Clin Invest; 1988 Aug; 18(4):369-74. PubMed ID: 2971546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin and atrial natriuretic peptide in pseudo-Bartter's syndrome.
    Sasaki H; Okumura M; Kawasaki T; Kangawa K; Matsuo H
    N Engl J Med; 1987 Jan; 316(3):167. PubMed ID: 2948126
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of prostaglandins in Bartter's syndrome.
    Winterborn MH; Hewitt GJ; Mitchell MD
    Int J Pediatr Nephrol; 1984 Mar; 5(1):31-8. PubMed ID: 6370882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of atrial natriuretic peptide are not always consistent with atrial pressure: is there alternative regulation as evidenced in Gordon's and Bartter's syndromes?
    Klemm SA; Gordon RD; Tunny TJ; Hawkins PG; Finn WL; Hamlet SM; Kewal NK; Purton KJ
    Clin Exp Pharmacol Physiol; 1989 Apr; 16(4):269-74. PubMed ID: 2525973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
    Ploier R; Tulzer W
    Wien Med Wochenschr; 1981; 131(11):287-93. PubMed ID: 7020264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J; Vallo A; Oliveros R
    Helv Paediatr Acta; 1978 Jun; 33(2):141-51. PubMed ID: 659258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of long-term treatment with spironolactone on sodium pump abnormalities in the red blood cells of patients with Bartter's syndrome.
    Horký K; Schreiber V; Dvoráková J
    Exp Clin Endocrinol; 1984 Jul; 84(1):105-11. PubMed ID: 6090182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma "prorenin"-renin in Bartter's syndrome, cystic fibrosis, and chloride deficiency, and the effect of prostaglandin synthetase inhibition.
    Chan LL; Osmond DH; Balfe JW; Halperin ML
    J Lab Clin Med; 1981 Jun; 97(6):785-90. PubMed ID: 6785370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tetany as a sole manifestation in a patient with Bartter's syndrome and a successful treatment with indomethacin].
    Fujihara K; Miyoshi T; Yamaguchi Y; Araki T; Tanaka K
    Rinsho Shinkeigaku; 1990 May; 30(5):529-32. PubMed ID: 2401113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bartter's syndrome. Differentiation into two clinical groups.
    Robson WL; Arbus GS; Balfe JW
    Am J Dis Child; 1979 Jun; 133(6):636-8. PubMed ID: 35973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of indomethacin on basal and saline-stimulated plasma atrial natriuretic factor levels in normal man.
    McKnight JA; Roberts G; Sheridan B; Atkinson AB
    Ir J Med Sci; 1991 Jul; 160(7):206-9. PubMed ID: 1836782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A circulating inhibitor of platelet aggregation in Bartter's syndrome.
    O'Reagan SO; Rivard GE; Mongeau JG; Robitaille PO
    Pediatrics; 1979 Dec; 64(6):939-41. PubMed ID: 117424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.